AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34146251 — intervention group
Group type: COMPARATOR
Intervention: Manual stainless-steel instrumentation
Number of subjects: 57
Study 34146251 — intervention group
Group type: COMPARATOR
Intervention: Manual instrumentation
Number of subjects: 57
Study 34146251 — intervention group
Group type: EXPERIMENTAL
Intervention: All systems
Number of subjects: 57
Study 32207137 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal Regional Anesthesia (CRA)
Number of subjects: 160
Study 32207137 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal Local Anesthesia (IRLA)
Number of subjects: 160
Study 32207137 — intervention group
Group type: COMPARATOR
Intervention: Periprostatic Local Anesthesia (PPLA)
Number of subjects: 160
Study 32207137 — intervention group
Group type: COMPARATOR
Intervention: Combined Local Anesthesia (IRLA+PPLA)
Number of subjects: 160
Study 34355753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6614
Study 34355753 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-regression
Number of subjects: 6614
Study 34355753 — intervention group
Group type: EXPERIMENTAL
Intervention: MetaForest
Number of subjects: 6614
Study 33792788 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab (RBZ) therapy, 0.5 or 2.0 mg, monthly intravitreal injections for 6 consecutive injections followed by as-needed treatments.
Number of subjects: 123
Study 32303377 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block with local anaesthetic (lidocaine 4% and ropivacaine 0.5%)
Number of subjects: 40
Study 32303377 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40
Study 32303377 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block with local anaesthetic
Number of subjects: 40
Study 35065922 — intervention group
Group type: EXPERIMENTAL
Intervention: FAITH! App (immediate intervention)
Number of subjects: 85
Study 35065922 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention comparator group
Number of subjects: 85
Study 33709192 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-soaked nasal packing (1 μg kg−1)
Number of subjects: 80
Study 33709192 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-soaked nasal packing (2 μg kg−1)
Number of subjects: 80
Study 33709192 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-soaked nasal packing (4 μg kg−1)
Number of subjects: 80
Study 33709192 — intervention group
Group type: COMPARATOR
Intervention: Normal saline-soaked nasal packing (Control)
Number of subjects: 80
Study 32346979 — intervention group
Group type: EXPERIMENTAL
Intervention: Citing predatory journal articles
Number of subjects: 204
Study 32346979 — intervention group
Group type: EXPERIMENTAL
Intervention: Four predatory journal articles
Number of subjects: 204
Study 32346979 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality evaluation of cited predatory articles
Number of subjects: 204
Study 33401694 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise
Number of subjects: 16
Study 33401694 — intervention group
Group type: COMPARATOR
Intervention: Resistance Exercise
Number of subjects: 16
Study 35026851 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC)
Number of subjects: 69
Study 35026851 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 69
Study 35026851 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut-umbilical cord milking (C-UCM)
Number of subjects: 69
Study 34941937 — intervention group
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Number of subjects: 408
Study 34941937 — intervention group
Group type: COMPARATOR
Intervention: PPI
Number of subjects: 408
Study 34941937 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined data from RCT and observational study
Number of subjects: 408
Study 36327043 — intervention group
Group type: EXPERIMENTAL
Intervention: SC‐R group (n=29) - 24 weeks of no cost Nicotine Replacement Treatment (NRT)
Number of subjects: 61
Study 36327043 — intervention group
Group type: EXPERIMENTAL
Intervention: SC + group (n=32) - 24 weeks of no cost NRT plus two initial individual counselling sessions of motivational interviewing and weekly psychosocial group support for 24 weeks
Number of subjects: 61
Study 36327043 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 61
Study 33855868 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor
Number of subjects: 0
Study 33855868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32109729 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills preparation group
Number of subjects: 174
Study 32109729 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth stories group
Number of subjects: 174
Study 32109729 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) group
Number of subjects: 174
Study 35238013 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia (OFA) technique
Number of subjects: 80
Study 35238013 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 80
Study 32847754 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIP)
Number of subjects: 588
Study 32847754 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 588
Study 33827012 — intervention group
Group type: EXPERIMENTAL
Intervention: CCT‐C‐PM intervention (Cognitive Compensatory Training)
Number of subjects: 72
Study 33827012 — intervention group
Group type: COMPARATOR
Intervention: Occupational therapy only
Number of subjects: 72
Study 35222879 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention combined with health education
Number of subjects: 70
Study 35222879 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 70
Study 33831949 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant cocktail (741 mg/d polyphenols, 2.1 g/d omega-3 fatty acids, 168 mg/d vitamin E, and 80 μg/d selenium)
Number of subjects: 20
Study 33831949 — intervention group
Group type: COMPARATOR
Intervention: No supplement (Control)
Number of subjects: 20
Study 34196905 — intervention group
Group type: EXPERIMENTAL
Intervention: Building Bridges to Fatherhood (BBTF) program
Number of subjects: 178
Study 34196905 — intervention group
Group type: COMPARATOR
Intervention: Money Smart Financial Literacy Program (MSFLP)
Number of subjects: 178
Study 35193619 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAM
Number of subjects: 24
Study 35193619 — intervention group
Group type: EXPERIMENTAL
Intervention: LEAD
Number of subjects: 24
Study 35193619 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAM + LEAD
Number of subjects: 24
Study 35193619 — intervention group
Group type: COMPARATOR
Intervention: Standard REP only
Number of subjects: 24
Study 33736821 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3730
Study 33736821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3730
Study 32703257 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge brokering intervention performed in 7 stages based on Dobbins' knowledge translation framework 2009.
Number of subjects: 100
Study 32703257 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control) without knowledge brokering intervention.
Number of subjects: 100
Study 36380749 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lung metastasis
Number of subjects: 618
Study 36380749 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival rates
Number of subjects: 618
Study 34791283 — intervention group
Group type: EXPERIMENTAL
Intervention: PP6M (700 or 1000 mg eq.)
Number of subjects: 702
Study 34791283 — intervention group
Group type: COMPARATOR
Intervention: PP3M (350 or 525 mg eq.)
Number of subjects: 702
Study 34791283 — intervention group
Group type: EXPERIMENTAL
Intervention: PP6M
Number of subjects: 702
Study 34791283 — intervention group
Group type: COMPARATOR
Intervention: PP3M
Number of subjects: 702
Study 34791283 — intervention group
Group type: COMPARATOR
Intervention: PP6M vs PP3M
Number of subjects: 702
Study 33259257 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise days (aerobic, high-intensity interval, or resistance-based exercise)
Number of subjects: 0
Study 33259257 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise days
Number of subjects: 0
Study 33259257 — intervention group
Group type: COMPARATOR
Intervention: Sedentary days
Number of subjects: 0
Study 32004582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrahypofractionated radiation therapy (UHF) - 7 × 6.1 Gy, 2.5 weeks
Number of subjects: 673
Study 32004582 — intervention group
Group type: COMPARATOR
Intervention: Conventionally fractionated radiation therapy (CF) - 39 × 2.0 Gy, 8 weeks
Number of subjects: 673
Study 34431071 — intervention group
Group type: EXPERIMENTAL
Intervention: Vosoritide 15 µg/kg
Number of subjects: 60
Study 34431071 — intervention group
Group type: EXPERIMENTAL
Intervention: Vosoritide 30 µg/kg
Number of subjects: 60
Study 34431071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32540887 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises, foot reflexology and back massage (BRM) with standard labour care
Number of subjects: 154
Study 32540887 — intervention group
Group type: COMPARATOR
Intervention: Standard labour care
Number of subjects: 154
Study 34554831 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-oxidising solution (AOS)
Number of subjects: 50
Study 34554831 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 50
Study 32217557 — intervention group
Group type: EXPERIMENTAL
Intervention: SFX-01 (300 mg)
Number of subjects: 90
Study 32217557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 34253584 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib (20 mg twice daily)
Number of subjects: 50
Study 34253584 — intervention group
Group type: COMPARATOR
Intervention: Ruxolitinib
Number of subjects: 50
Study 34253584 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 50
Study 34694204 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive fusion of the sacroiliac joint
Number of subjects: 60
Study 34694204 — intervention group
Group type: COMPARATOR
Intervention: Sham operation
Number of subjects: 60
Study 33605509 — intervention group
Group type: COMPARATOR
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 45
Study 33605509 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impulsive individuals
Number of subjects: 45
Study 33605509 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-impulsive individuals
Number of subjects: 45
Study 33605509 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-trial preresponse theta phase clustering
Number of subjects: 45
Study 33605509 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance monitoring
Number of subjects: 45
Study 33605509 — intervention group
Group type: EXPERIMENTAL
Intervention: Current stimulation protocol
Number of subjects: 45
Study 32154847 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 148
Study 32154847 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy
Number of subjects: 148
Study 35963416 — intervention group
Group type: EXPERIMENTAL
Intervention: R. damascena and brown sugar syrup (0.1 g R. damascena petals mixed with 0.85 g brown sugar per 1 mL)
Number of subjects: 100
Study 35963416 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene Glycol (PEG)
Number of subjects: 100
Study 35963416 — intervention group
Group type: EXPERIMENTAL
Intervention: R. damascena and brown sugar syrup
Number of subjects: 100
Study 34135392 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with music listening (tDCS + Music)
Number of subjects: 14
Study 34135392 — intervention group
Group type: COMPARATOR
Intervention: tDCS in silence (tDCS-only)
Number of subjects: 14
Study 34135392 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS with music listening (Sham + Music)
Number of subjects: 14
Study 34135392 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS + Music
Number of subjects: 14
Study 36151947 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle flexor tendon tenotomy treatment
Number of subjects: 95
Study 36151947 — intervention group
Group type: COMPARATOR
Intervention: Standard nonsurgical treatment alone
Number of subjects: 95
Study 32493720 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV Env subunit vaccine
Number of subjects: 15
Study 32493720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 35056358 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc Blue
Number of subjects: 51
Study 35056358 — intervention group
Group type: COMPARATOR
Intervention: Protaper NEXT
Number of subjects: 51
Study 36115523 — intervention group
Group type: EXPERIMENTAL
Intervention: Deucravacitinib 6 mg QD
Number of subjects: 1020
Study 36115523 — intervention group
Group type: COMPARATOR
Intervention: Apremilast 30 mg BID
Number of subjects: 1020
Study 34416381 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumentation at 0.0 measurement
Number of subjects: 40
Study 34416381 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumentation at 0.0 measurement + PDT
Number of subjects: 40
Study 34416381 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumentation 1mm beyond 0.0 measurement
Number of subjects: 40
Study 34416381 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumentation 1mm beyond 0.0 measurement + PDT
Number of subjects: 40
Study 32713104 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dual therapy (HDDT) with rabeprazole 20 mg q.i.d. and amoxicillin 1 g q.i.d. for 14 days
Number of subjects: 191
Study 32713104 — intervention group
Group type: COMPARATOR
Intervention: Standard triple therapy (STT) with rabeprazole 20 mg b.i.d., amoxicillin 1 g b.i.d., and clarithromycin 500 mg b.i.d. for 14 days
Number of subjects: 191
Study 32713104 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dual therapy (HDDT)
Number of subjects: 191
Study 32713104 — intervention group
Group type: COMPARATOR
Intervention: Standard triple therapy (STT)
Number of subjects: 191
Study 35270527 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Workplace Violence Prevention and Management Training Program
Number of subjects: 75
Study 34724899 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded walking protocol with biweekly phone calls for compliance monitoring
Number of subjects: 45
Study 34724899 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention or biweekly monitoring)
Number of subjects: 45
Study 32153209 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire item 9 response of 2 or 3
Number of subjects: 2928927
Study 32153209 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire item 9 response of 3
Number of subjects: 2928927
Study 32153209 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide risk score of 90th percentile or higher
Number of subjects: 2928927
Study 32153209 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide risk score of 95th percentile or higher
Number of subjects: 2928927
Study 32153209 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide risk score of 99th percentile or higher
Number of subjects: 2928927
Study 34936109 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior palatoplasty and expansion sphincter pharyngoplasty (APwESP)
Number of subjects: 91
Study 32246662 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nitroglycerin ointment
Number of subjects: 550
Study 32246662 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diltiazem ointment
Number of subjects: 550
Study 32246662 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical lateral internal sphincterotomy
Number of subjects: 550
Study 35020928 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral features alone (CXR)
Number of subjects: 1321
Study 35020928 — intervention group
Group type: COMPARATOR
Intervention: Normal CXRs
Number of subjects: 1321
Study 35020928 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent viral features and radiographic pneumonia
Number of subjects: 1321
Study 35020928 — intervention group
Group type: COMPARATOR
Intervention: Radiographic pneumonia alone
Number of subjects: 1321
Study 34631651 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroponic planting integrated with health promotion activities (two times per week for 8 months)
Number of subjects: 553
Study 34631651 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion activities (one time per week for 6 weeks)
Number of subjects: 553
Study 34631651 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroponic planting integrated with health promotion activities
Number of subjects: 553
Study 34631651 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 553
Study 34747975 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontrast CT
Number of subjects: 1604
Study 34747975 — intervention group
Group type: EXPERIMENTAL
Intervention: CTP
Number of subjects: 1604
Study 34747975 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 1604
Study 33289822 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (960 mg orally twice daily)
Number of subjects: 342
Study 33289822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study 34546408 — intervention group
Group type: EXPERIMENTAL
Intervention: TMT (a newly developed five-session couple-focused intervention)
Number of subjects: 60
Study 34546408 — intervention group
Group type: COMPARATOR
Intervention: TAU (usual care)
Number of subjects: 60
Study 34546408 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TMT and TAU
Number of subjects: 60
Study 34228547 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotic agents
Number of subjects: 224
Study 34228547 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline-rifampicin
Number of subjects: 224
Study 34228547 — intervention group
Group type: COMPARATOR
Intervention: 7-day treatment
Number of subjects: 224
Study 34228547 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 224
Study 34228547 — intervention group
Group type: COMPARATOR
Intervention: Immunocompromised status
Number of subjects: 224
Study 32032673 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian eaters
Number of subjects: 0
Study 32032673 — intervention group
Group type: COMPARATOR
Intervention: Omnivorous group
Number of subjects: 0
Study 33400412 — intervention group
Group type: EXPERIMENTAL
Intervention: VP-102 (0.7% w/v cantharidin) applied topically every 21 days for a maximum of 4 treatments.
Number of subjects: 33
Study 33400412 — intervention group
Group type: EXPERIMENTAL
Intervention: VP-102 (0.7% w/v cantharidin)
Number of subjects: 33
Study 33400412 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic exposure group (VP-102)
Number of subjects: 33
Study 33120757 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishentongluo decoction (YSTL)
Number of subjects: 160
Study 33120757 — intervention group
Group type: COMPARATOR
Intervention: Levocarnitine oral solution
Number of subjects: 160
Study 34445938 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive techniques
Number of subjects: 86
Study 33767255 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow squat training (SS group)
Number of subjects: 16
Study 33767255 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep squat training (DS group)
Number of subjects: 16
Study 32234700 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) app used for 6 weeks
Number of subjects: 312
Study 32234700 — intervention group
Group type: COMPARATOR
Intervention: Patient Education (PE) through the app
Number of subjects: 312
Study 35020023 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA) 20 ml of 5% solution
Number of subjects: 85
Study 35020023 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control) 20 ml
Number of subjects: 85
Study 35020023 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA)
Number of subjects: 85
Study 35020023 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 85
Study 33757437 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet alongside standard therapy
Number of subjects: 36
Study 33757437 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 36
Study 33757437 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 36
Study 33277579 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-intervention (15 min)
Number of subjects: 2
Study 34415079 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing Aid (HA) use with baseline accommodations for 12 weeks
Number of subjects: 34
Study 34415079 — intervention group
Group type: COMPARATOR
Intervention: Baseline accommodations only for 12 weeks
Number of subjects: 34
Study 33462096 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 198
Study 33462096 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin
Number of subjects: 198
Study 33462096 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 198
Study 32270476 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinse-free hand washing
Number of subjects: 30747
Study 33534264 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (0.02 mg/kg bolus followed by 0.01 mg/kg/hour for 24 hours)
Number of subjects: 261
Study 33534264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study 33534264 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 261
Study 34320232 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized clinical trials for Wilson disease
Number of subjects: 0
Study 34320232 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooling of data from standardized clinical trials
Number of subjects: 0
Study 32535711 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (1000 mg/m2) plus Oxaliplatin (100 mg/m2) every 2 weeks
Number of subjects: 45
Study 32535711 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus Oxaliplatin (GEMOX)
Number of subjects: 45